No major differences were detected between PIM1 and NOTCH3 mRNA expression levels in different breast cancer stages, whereas the PIM1 levels were reduced in most subtypes as compared with control samples (Fig. S2, A–D). This evidence concerns the gene NOTCH3 and breast cancer.